Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression

Phytomedicine

Volumn 21, Issue 7, 2014, Pages 998-1003

  Zhou, Yun ^a   Li, Hui Qin ^a   Lu, Lin ^a   Fu, Deng Lei ^a   Liu, Ai Ju ^a   Li, Ji Huang ^a   Zheng, Guo Qing ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Aquaporin 4; Blood brain barrier disruption; Ginsenoside Rg1; Neuroprotection; Stroke

Indexed keywords

ACETAZOLAMIDE; AQUAPORIN 4; GINSENOSIDE RG 1; SOYBEAN OIL; AQP4 PROTEIN, RAT; GINSENOSIDE; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

PANAX GINSENG; RATTUS;

ANIMALS; AQUAPORIN 4; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; GINSENOSIDES; MALE; NEUROPROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84901612797     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.12.005     Document Type: Article

References (33)

1. C.V. Borlongan, A.A. Rodrigues Jr., and M.C. Oliveira Breaking the barrier in stroke: what should we know? A mini-review Current Pharmaceutical Design 18 2012 3615 3623
2. M.D. Ginsberg Neuroprotection for ischemic stroke: past, present and future Neuropharmacology 55 2008 363 389
3. E.C. Jauch, J.L. Saver, H.P. Adams Jr., A. Bruno, J.J. Connors, B.M. Demaerschalk, P. Khatri, P.W. McMullan Jr., A.I. Qureshi, K. Rosenfield, P.A. Scott, D.R. Summers, D.Z. Wang, M. Wintermark, and H. Yonas Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke; A Journal of Cerebral Circulation 44 2013 870 947
4. B. Jiang, Z. Xiong, J. Yang, W. Wang, Y. Wang, Z.L. Hu, F. Wang, and J.G. Chen Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus British Journal of Pharmacology 166 2012 1872 1887
5. Y.C. Kim, S.R. Kim, G.J. Markelonis, and T.H. Oh Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration Journal of Neuroscience Research 53 1998 426 432
6. L.L. Latour, D.W. Kang, M.A. Ezzeddine, J.A. Chalela, and S. Warach Early blood-brain barrier disruption in human focal brain ischemia Annals of Neurology 56 2004 468 477
7. K.W. Leung, and A.S. Wong Pharmacology of ginsenosides: a literature review Chinese Medicine 5 2010 20
8. A. Lipsanen, and J. Jolkkonen Experimental approaches to study functional recovery following cerebral ischemia Cellular and Molecular Life Sciences: CMLS 68 2011 3007 3017
9. Z.Q. Liu, X.Y. Luo, G.Z. Liu, Y.P. Chen, Z.C. Wang, and Y.X. Sun In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes Journal of Agricultural and Food Chemistry 51 2003 2555 2558
10. E.Z. Longa, P.R. Weinstein, S. Carlson, and R. Cummins Reversible middle cerebral artery occlusion without craniectomy in rats Stroke; A Journal of Cerebral Circulation 20 1989 84 91
11. J.M. Lu, Q. Yao, and C. Chen Ginseng compounds: an update on their molecular mechanisms and medical applications Current Vascular Pharmacology 7 2009 293 302
12. S.Y. Nah, D.H. Kim, and H. Rhim Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Reviews 13 2007 381 404
13. M.E. O'Donnell, L. Tran, T.I. Lam, X.B. Liu, and S.E. Anderson Bumetanide inhibition of the blood-brain barrier Na-K-Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 24 2004 1046 1056
14. M.C. Papadopoulos, G.T. Manley, S. Krishna, and A. Verkman Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema The FASEB Journal 18 2004 1291 1293
15. M.C. Papadopoulos, and A.S. Verkman Aquaporin-4 and brain edema Pediatric Nephrology 22 2007 778 784
16. E.K. Park, M.K. Choo, J.K. Oh, J.H. Ryu, and D.H. Kim Ginsen-oside Rh2 reduces ischemic brain injury in rats Biological & Pharmaceutical Bulletin 27 2004 433 436
17. C. Qu, Y. Bai, X. Jin, Y. Wang, K. Zhang, J. You, and H. Zhang Study on ginsenosides in different parts and ages of Panax quinquefolius L. Food Chemistry 115 2009 340 346
18. C. Ribeiro Mde, L. Hirt, J. Bogousslavsky, L. Regli, and J. Badaut Time course of aquaporin expression after transient focal cerebral ischemia in mice Journal of Neuroscience Research 83 2006 1231 1240
19. S. Saadoun, and M.C. Papadopoulos Aquaporin-4 in brain and spinal cord oedema Neuroscience 168 2010 1036 1046
20. K.E. Sandoval, and K.A. Witt Blood-brain barrier tight junction permeability and ischemic stroke Neurobiology of Disease 32 2008 200 219
21. R.C. Seet, and A.A. Rabinstein Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions Cerebrovascular Diseases (Basel, Switzerland) 34 2012 106 114
22. L. Shen, and J. Zhang NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils Neurological Research 29 2007 270 273
23. M.S. Siddique, F. Eddeb, D. Mantle, and A.D. Mendelow Extracts of Ginkgo biloba and Panax ginseng protect brain proteins from free radical induced oxidative damage in vitro Acta Neurochirurgica Supplement 76 2000 87 90
24. K. Strong, C. Mathers, and R. Bonita Preventing stroke: saving lives around the world Lancet Neurology 6 2007 182 187
25. B. Tang, Y. Qu, D. Wang, and D. Mu Targeting hypoxia inducible factor-1alpha: a novel mechanism of ginsenoside Rg1 for brain repair after hypoxia/ischemia brain damage CNS & Neurological Disorders Drug Targets 10 2011 235 238
26. Y. Tanimura, Y. Hiroaki, and Y. Fujiyoshi Acetazolamide reversibly inhibits water conduction by aquaporin-4 Journal of Structural Biology 166 2009 16 21
27. J. Tian, S. Zhang, G. Li, Z. Liu, and B. Xu 20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain Phytotherapy Research 23 2009 486 491
28. A. Towfighi, and J.L. Saver Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead Stroke; A Journal of Cerebral Circulation 42 2011 2351 2355
29. R. Ye, X. Kong, Q. Yang, Y. Zhang, J. Han, and G. Zhao Ginsen-oside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice Neuropharmacology 61 2011 815 824
30. B. Zhang, R. Hata, P. Zhu, K. Sato, T.C. Wen, L. Yang, H. Fujita, N. Mitsuda, J. Tanaka, K. Samukawa, N. Maeda, and M. Sakanaka Prevention of ischemic neuronal death by intravenous infusion of a ginseng saponin, ginsenoside Rb(1), that upregulates Bcl-x(L) expression Journal of Cerebral Blood Flow and Metabolism 26 2006 708 721
31. Y.F. Zhang, X.J. Fan, X. Li, L.L. Peng, G.H. Wang, K.F. Ke, and Z.L. Jiang Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels European Journal of Pharmacology 586 2008 90 99
32. G.Q. Zheng, W. Cheng, Y. Wang, X.M. Wang, S.Z. Zhao, Y. Zhou, S.J. Liu, and X.T. Wang Ginseng total saponins enhance neurogenesis after focal cerebral ischemia Journal of Ethnopharmacology 133 2011 724 728
33. G.Q. Zheng, X.M. Wang, Y. Wang, and X.T. Wang Tau as a potential novel therapeutic target in ischemic stroke Journal of Cellular Biochemistry 109 2010 26 29